Clinical Trial Update: STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT [Phase 1]

View source ↗

Summary

Pfizer's PF-06882961 was studied in a Phase 1 trial in adults with Type 2 diabetes mellitus, including participants with varying degrees of renal impairment and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-06882961

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2, Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2024-05-10